Browse Title Index
Issue Title
Vol 10, No 2 (2014) National oncology network Abstract   PDF (Polish)
Krzysztof Warzocha
Vol 11, No 6 (2015) Neoadjuvant treatment in a patient with HER2-positive breast cancer — a case study and review of recent recommendations Abstract   PDF   HTML
Małgorzata Kruszwicka, Radosław Lisiecki
Vol 15, No 2 (2019) Neratinib in adjuvant treatment of patients with HER2-positive breast cancer — less is more? Abstract   PDF
Ewa Cedrych, Ida Cedrych
Vol 16, No 4 (2020) Neratinib in extended adjuvant therapy for HER2-positive early breast cancer Abstract   PDF
Tomasz Kubiatowski
Vol 14, No 5 (2018) Neuroendocrine rectal tumour as a rare aetiology of adult recto-sigmoidal intussusception: case presentation and literature review Abstract   PDF
Matei Razvan Bratu, Tudor Marinescu, Bogdan Cristea, Bogdan Ionut Diaconescu
Online first Neuroendocrine rectal tumour as a rare aetiology of adult recto-sigmoidal intussusception: case presentation and literature review Abstract   PDF
Matei Razvan Bratu, Tudor Marinescu, Bogdan Cristea, Bogdan Ionut Diaconescu
Online first Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy Abstract   PDF
Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka
Online first ERRATUM: Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy Abstract
Ireneusz Raczyński, Agnieszka Siedlaczek, Joanna Streb, Patryk Zając, Bogumiła Czartoryska-Arłukowicz, Aleksandra Chruściana-Bołtuć, Małgorzata Talerczyk, Katarzyna Wierzbicka, Weronika Radecka, Michał Jurczyk, Barbara Radecka
Vol 3, No 5 (2007) New approach to postoperative adjuvant treatment in non-small-cell lung cancer Abstract   PDF (Polish)
Maciej Krzakowski
Vol 16, No 6 (2020) New dosing schedule of pembrolizumab — theoretical basis and scientific evidence Abstract   PDF
Dorota Szcześ, Piotr Rutkowski
Vol 3, No 1 (2007) New options in systemic adjuvant therapy of breast cancer Abstract   PDF (Polish)
Maciej Krzakowski
Vol 18, No 5 (2022) New scoring system as predictor of 90-day mortality in appendicular skeletal metastases Abstract   PDF   HTML
I Gede Eka Wiratnaya, Hans Kristian Nugraha, I Gusti Ngurah Wien Aryana, Putu Astawa
Vol 13, No 4 (2017) New treatment options for patients with metastatic colorectal cancer in Poland Abstract   PDF   HTML
Magdalena Krakowska, Piotr Potemski
Vol 19, No 5 (2023) News and updates in the treatment of localized stage triple-negative breast cancer Abstract   PDF   HTML
Irene Solana López, Juan Antonio Guerra Martínez, Diego Malón Giménez, Laura Rodríguez Lajusticia, Carmen Pantín González, Ana Manuela Martín Fernández de Soignie, Carlos de Zea Luque, Beatriz Losada Vila, Nadia Sánchez Baños, Fátima Escalona Martín, Elia Martínez Moreno, David Gutiérrez Abad, Ignacio Juez Martel, Beatriz Jiménez Munarriz, Julia Calzas Rodríguez
Vol 10, Supp. A (2014) Niewydolność serca w trakcie leczenia sunitynibem u pacjentki z rozsianym rakiem nerki Details   PDF (Polish)
Paweł Nurzyński, Ewa Pierzchała, Andrzej Deptała
Vol 19, No 6 (2023) Niraparib maintenance in newly diagnosed advanced ovarian cancer — review and case series Abstract   PDF   HTML
Martyna Tyszka, Rafał Stec
Vol 15, No 2 (2019) Nivolumab in the treatment of advanced renal cell carcinoma Abstract   PDF
Piotr Tomczak, Zuzanna Synowiec
Vol 19, No 4 (2023) Nivolumab in the treatment of thoracic cancer — new possibilities Abstract   PDF   HTML
Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk
Vol 15, No 1 (2019) Nivolumab in treatment of renal cell carcinoma during renal replacement therapy Abstract   PDF
Kamil Konopka
Vol 14, No 4 (2018) Nivolumab therapy for refractory and relapsed Hodgkin’s lymphoma — case report Abstract   PDF
Marta Macioch, Piotr Centkowski
Online first Nivolumab therapy for refractory and relapsed Hodgkin’s lymphoma — case report Abstract   PDF
Marta Macioch, Piotr Centkowski
Vol 12, No 2 (2016) Nivolumab — perspectives in cancer treatment Abstract   PDF
Hanna Koseła, Piotr Rutkowski
Vol 20, No 3 (2024) Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland Abstract   PDF
Michał Seweryn, Tomasz Banaś, Joanna Augustyńska, Agnieszka Leszczyńska, Paweł M. Potocki
Vol 6, Supp. A (2010) Non-pegylated liposomal doxorubicin use in the treatment of bilateral breast cancer Abstract   PDF (Polish)
Monika Nowaczyk
Vol 10, Supp. G (2014) Non-small lung cancer patent with mutations in EGFR gene — diagnostic case Abstract   PDF (Polish)
Tomasz Pacuszko
651 - 675 of 1173 Items <<   <   22 23 24 25 26 27 28 29 30 31   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl